N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide

C124H121F13N18O15 — CID 158092882

IUPACN-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide
SMILESCCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(C(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1
InChIInChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H20F3N3O2.C21H23N3O3.C20H19F2N3O2.C20H20FN3O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;1-3-13-4-6-14(7-5-13)10-18(23-12(2)26)20-25-24-19(27-20)15-8-9-16(21)17(22)11-15;1-3-14-7-9-15(10-8-14)11-18(22-13(2)25)20-24-23-19(26-20)16-5-4-6-17(21)12-16/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-9,11,18H,3,10H2,1-2H3,(H,23,26);4-10,12,18H,3,11H2,1-2H3,(H,22,25)
InChIKeyFOHZRVUQSMTBRM-UHFFFAOYSA-N
MW2350.42 g/mol
LogP25.69
Rot. Bonds39

About N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide

N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide (PubChem CID 158092882) has the molecular formula C124H121F13N18O15 and a molecular weight of 2350.42 g/mol. Its IUPAC name is N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide.

Molecular Properties

Compound NameN-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide
PubChem CID158092882
Molecular FormulaC124H121F13N18O15
Molecular Weight2350.42 g/mol
Exact Mass2348.91
IUPAC NameN-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide
SMILESCCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(C(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1
InChIInChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H20F3N3O2.C21H23N3O3.C20H19F2N3O2.C20H20FN3O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;1-3-13-4-6-14(7-5-13)10-18(23-12(2)26)20-25-24-19(27-20)15-8-9-16(21)17(22)11-15;1-3-14-7-9-15(10-8-14)11-18(22-13(2)25)20-24-23-19(26-20)16-5-4-6-17(21)12-16/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-9,11,18H,3,10H2,1-2H3,(H,23,26);4-10,12,18H,3,11H2,1-2H3,(H,22,25)
InChIKeyFOHZRVUQSMTBRM-UHFFFAOYSA-N
XLogP25.69
TPSA435.81 Ų
H-Bond Donors6
H-Bond Acceptors27
Rotatable Bonds39
Heavy Atoms170
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002350.42
LogP ≤ 525.69
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1027

Analyze N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?
The IUPAC name of N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide (CID 158092882) is N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide.
What is the SMILES notation for N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?
The canonical SMILES for N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide is CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(C(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cccc(OC)c3)o2)cc1.
What is the InChIKey of N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?
The InChIKey is FOHZRVUQSMTBRM-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H19F4N3O3.C21H20F3N3O3.C21H20F3N3O2.C21H23N3O3.C20H19F2N3O2.C20H20FN3O2/c1-3-13-4-6-14(7-5-13)10-17(26-12(2)29)20-28-27-19(30-20)15-8-9-16(22)18(11-15)31-21(23,24)25;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)30-21(22,23)24;1-3-14-7-9-15(10-8-14)11-18(25-13(2)28)20-27-26-19(29-20)16-5-4-6-17(12-16)21(22,23)24;1-4-15-8-10-16(11-9-15)12-19(22-14(2)25)21-24-23-20(27-21)17-6-5-7-18(13-17)26-3;1-3-13-4-6-14(7-5-13)10-18(23-12(2)26)20-25-24-19(27-20)15-8-9-16(21)17(22)11-15;1-3-14-7-9-15(10-8-14)11-18(22-13(2)25)20-24-23-19(26-20)16-5-4-6-17(21)12-16/h4-9,11,17H,3,10H2,1-2H3,(H,26,29);4-10,12,18H,3,11H2,1-2H3,(H,25,28);4-10,12,18H,3,11H2,1-2H3,(H,25,28);5-11,13,19H,4,12H2,1-3H3,(H,22,25);4-9,11,18H,3,10H2,1-2H3,(H,23,26);4-10,12,18H,3,11H2,1-2H3,(H,22,25).
What are the key properties of N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide?
N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide has a molecular weight of 2350.42 g/mol, XLogP of 25.69, 39 rotatable bonds, 6 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[4-fluoro-3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide;N-[2-(4-ethylphenyl)-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]acetamide is sourced from PubChem (CID 158092882), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).